What is CopyPro?
CopyPro operates within the advanced laboratory automation sector, specializing in the design and manufacturing of cutting-edge solutions for liquid handling, sample preparation, and sample management. Their innovative product lines, including the firefly and mosquito systems, are engineered to enhance scientific research workflows across critical areas such as genomics, drug discovery, and structural biology. By partnering with global leaders, CopyPro co-creates solutions that tackle complex laboratory challenges, thereby accelerating life science research and contributing to advancements in human health.
How much funding has CopyPro raised?
CopyPro has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CopyPro?
The substantial backing CopyPro has received, particularly the recent strategic investment, positions the company for accelerated scaling and market penetration. This capital infusion is likely to fuel further research and development into next-generation lab automation technologies, potentially expanding their product portfolio and global reach. The company's focus on enhancing scientific research workflows suggests a strategic direction aimed at solidifying its position as a key enabler of breakthroughs in life sciences and biotechnology.
See full CopyPro company page